Source: Epsilon Healthcare
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Epsilon Healthcare (EPN) extends its agreement with The Valens Company to January 31
  • The deal gives The Valens Company access to Epsilon’s Southport manufacturing facility to further Valens’ international expansion into the Asia-Pacific, Latin America, European and UK markets
  • In return, Valens will grant Epsilon a license to use its intellectual property in operating the Southport Facility and fund all future operational and capital expenditure for the duration of the partnership on a reimbursement basis
  • Epsilon and Valens have extended the date of the agreement to allow additional time to settle the deal
  • Epsilon Healthcare drops 8.7 per cent, trading at 10.5 cents per share at 2:50 pm AEDT

Epsilon Healthcare (EPN) has extended its agreement with The Valens Company to January 31, 2022.

Epsilon announced a long-term exclusive partnership with the Canada-based manufacturer of cannabis products in September 2021. The deal gives access to Epsilon’s Southport manufacturing facility to further Valens’ international expansion into the Asia-Pacific, Latin America, European and UK markets.

Epsilon’s facility is considered the largest cannabis extraction facility in the Southern Hemisphere, allowing Valens the opportunity to deliver GMP-grade products.

In return, Valens will grant Epsilon a license to use its intellectual property in operating the Southport Facility and will provide personnel and support.

Valens will also fund all future operational and capital expenditures of the Southport Facility for the duration of the partnership on a reimbursement basis.

Epsilon and Valens extended the date of the agreement to allow additional time to settle the deal.

“We are pleased at the progress made under the Epsilon and Valens partnership since its inception in September,” said Jarrod White, Chief Executive Officer of Epsilon.

“We look forward to executing formal agreements with Valens to take the Epsilon Southport Facility to a global scale, and towards delivering on key orders for local and export markets in early 2022 and beyond.”

Epsilon Healthcare dropped 8.7 per cent, trading at 10.5 cents per share at 2:50 pm AEDT.

EPN by the numbers
More From The Market Herald

" Vital Metals (ASX:VML) to redesign pit at Nechalacho following ore discovery

Vital Metals (ASX:VML) completes maiden mining and ore sorting campaign at its Nechalacho rare earths project…
Brookside Energy (ASX:BRK)- Managing Director, David Prentice

" Brookside Energy (ASX:BRK) sees its quarter revenue skyrocket

Brookside Energy (ASX:BRK) sees its fourth quarter revenue sales skyrocket 800 per cent on quarter to…
Titomic (ASX:TTT) - Incoming Managing Director, Herbert Koeck

" Titomic (ASX:TTT) reshuffles board

Titomic’s (ASX:TTT) Chief Executive Officer, Herbert Koeck has been appointed Managing Director of the company.
Dreadnought Resources (ASX:DRE) - Managing Director, Dean Tuck

" Dreadnought Resources (ASX:DRE) reports delays in results as activity ramps up

Dreadnought Resources (ASX:DRE) said certain results have been delayed until February due to industry-wide obstructions.